Skip to main content
SpringerLink
Log in
Book cover

Imaging and Focal Therapy of Early Prostate Cancer pp 3–19Cite as

Evolution in the Concept of Focal Therapy: The Story of Breast Cancer and Prostate Cancer

  • Chapter
  • First Online:

  • 995 Accesses

Part of the book series: Current Clinical Urology ((CCU))

Abstract

Prostate cancer is characterized by a low mortality—incidence ratio partially due to the diagnosis of localized and low-risk disease. Focal therapy for prostate cancer has evolved in order to address the need for treatment of localized disease without exposing patients to the morbidities associated with radical therapy such as incontinence and erectile dysfunction and thus allowing them to maintain a good quality of life. In women, similarly to prostate cancer, the overdiagnosis of breast cancer due to improved imaging has induced the progression of surgical techniques from radical mastectomy to a more focal approach with individualized breast conservative strategies. In the following chapter, we will be reviewing the evolution of focal therapy in breast and prostate cancer and will examine what were the factors that drove this evolution in time.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. GLOBOCAN 2012 (IARC), The World Bank Group 2014 Indicators. 2014. http://globocan.iarc.fr/; http://data.worldbank.org/indicator/NY.GDP.PCAP.CD.

  2. Halsted W. The results of operation for the cure of the cancer breast performed at the John Hopkins Hospital, from June 1889 to January 1894. Bull Johns Hopkins Hosp. 1894;4:297–350.

    Google Scholar 

  3. Patey DH, Dyson WH. The prognosis of carcinoma of the breast in relation to the type of mastectomy performed. Br J Cancer. 1948;2:7–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Mustakalio S. Treatment of breast cancer by tumor extirpation and roentgen therapy instead of radical operation. J Fac Radiol. 1954;6:23–7.

    Article  Google Scholar 

  5. Kennedy CS, Miller E. Simple mastectomy for mammary carcinoma. Ann Surg. 1963;157:161–2.

    CAS  PubMed  Google Scholar 

  6. Auchincloss H. Significance of location and number of axillary metastases in carcinoma of the breast: a justification for a conservative operation. Ann Surg. 1963;158:37–46.

    Article  CAS  PubMed  Google Scholar 

  7. Madden JL. Modified radical mastectomy. Surg Gynecol Obstet. 1965;121(6):1221–30.

    CAS  PubMed  Google Scholar 

  8. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–41.

    Article  PubMed  Google Scholar 

  9. Black DM, Hunt KK, EA M, DM B, KK H. Long-term outcomes reporting the safety of breast conserving therapy compared to mastectomy: 20-year results of EORTC 10801. Gland Surg. 2013;2(3):120–3.

    PubMed  PubMed Central  Google Scholar 

  10. Hayward J. The conservative treatment of early breast cancer. Cancer. 1974;33(2):593–9.

    Article  CAS  PubMed  Google Scholar 

  11. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347(8):567–75.

    Article  PubMed  Google Scholar 

  12. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–32.

    Article  PubMed  Google Scholar 

  13. American College of Radiology. ACR practice parameter for the performance of screening and diagnostic mammography. Amended 2014 (Resolution 39). http://www.acr.org/~/media/ACR/Documents/PGTS/guidelines/Image_Quality_Digital_Mammo.pdf. Accessed 12 Sept 2016.

  14. Yang T-L, Liang H-L, Chou C-P, Huang J-S, Pan H-B. The adjunctive digital breast tomosynthesis in diagnosis of breast cancer. BioMed Res Int. 2013;2013:7, Article ID 597253.

    Google Scholar 

  15. Mainiero MB, Bailey L, D’Orsi C, Green ED, Holbrook AI, Lee S-J, et al. Breast cancer screening. American College of Radiology. ACR Appropriateness Criteria®. 2012. https://acsearch.acr.org/docs/70910/Narrative/. Accessed 12 Sept 2016.

  16. D’Orsi CJ, Bassett LW, Feig SA, et al. Illustrated Breast Imaging Reporting and Data System: Illustrated BI-RADS. 5th ed. Reston: American College of Radiology; 2013.

    Google Scholar 

  17. Pilar Gazmuri P, Arturo EN. Mamografía “full digital” directa o en campo completo. Experiencia preliminar. Rev Chil Obstet Ginecol. 2002;67(5):343–8.

    Google Scholar 

  18. Helvie MA. Digital mammography imaging: breast tomosynthesis and advanced applications. Radiol Clin N Am. 2010;48(5):917–29.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Kim SA, Chang JM, Cho N, Yi A, Moon WK. Characterization of breast lesions: comparison of digital breast tomosynthesis and ultrasonography. Korean J Radiol. 2015;16(2):229–38.

    Article  PubMed  PubMed Central  Google Scholar 

  20. American College of Radiology. ACR practice parameter for the performance of a breast ultrasound examination. Amended 2016 (Resolution 38). http://www.acr.org/~/media/ACR/Documents/PGTS/guidelines/US_Breast.pdf. Accessed 12 Sept 2016.

  21. Ophir J, Céspedes I, Ponnekanti H, Yazdi Y, Li X. Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrason Imaging. 1991;13(2):111–34.

    Article  CAS  PubMed  Google Scholar 

  22. Gong X, Wang Y, P X. Application of real-time ultrasound elastography for differential diagnosis of breast tumors. J Ultrasound Med. 2013;32:2171–6.

    Article  PubMed  Google Scholar 

  23. Gheonea IA, Stoica Z, Bondari S. Differential diagnosis of breast lesions using ultrasound elastography. Indian J Radiol Imaging. 2011;21(4):301–5.

    Article  PubMed  PubMed Central  Google Scholar 

  24. American College of Radiology. ACR practice parameter for the performance of contrast enhanced magnetic resonance imaging (MRI) of the breast. Amended 2013 (Resolution 12). http://www.acr.org/~/media/2a0eb28eb59041e2825179afb72ef624.pdf

  25. ACR BI-RADS Atlas. http://www.acr.org/Quality-Safety/Resources/BIRADS. Accessed 12 Sept 2016.

  26. Heywang-Köbrunner SH, Heinig A, Pickuth D, Alberich T, Spielman RP. Interventional MRI of the breast: lesion localization and biopsy. Eur Radiol. 2000;10:36–45.

    Article  PubMed  Google Scholar 

  27. Westenend PJ, Sever AR, Beekman-De Volder HJ, Liem SJ. A comparison of aspiration cytology and core needle biopsy in the evaluation of breast lesions. Cancer. 2001;93:146–50.

    Article  CAS  PubMed  Google Scholar 

  28. Schoonjans JM, Brem RF. Fourteen-gauge ultrasonographically guided large-core needle biopsy of breast masses. J Ultrasound Med. 2001;20(9):967–72.

    Article  CAS  PubMed  Google Scholar 

  29. Morrow M, Strom EA, Bassett LW, Dershaw DD, Fowble B, Giuliano A, American College of Radiology, American College of Surgeons, Society of Surgical Oncology, College of American Pathology, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin. 2002;52(5):277–300.

    Article  PubMed  Google Scholar 

  30. Kwong A, Sabel M. Mastectomy: indications, types, and concurrent axillary lymph node management. http://www.uptodate.com/contents/mastectomy-indications-types-and-concurrent-axillary-lymph-node-management. Accessed 12 Sept 2016.

  31. Schwartz GF, Giuliano AE, Veronesi U, Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania. Cancer. 2002;94(10):2542–51.

    Article  PubMed  Google Scholar 

  32. Cabañas R. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456–66.

    Article  PubMed  Google Scholar 

  33. Hernandez Muñoz G, Barros AC, et al. Ganglio Centinela en Mastología. Editorial Médica Panamericana SA. 2006;75–81.

    Google Scholar 

  34. Hernández G, Contreras A, Betancourt L, Acosta V, Pérez BR, Gómez A, et al. Reunión de consenso ganglio centinela en carcinoma de mama. Rev Venez Oncologia. 2010;22(2):133–41.

    Google Scholar 

  35. National Cancer Institute. http://www.cancer.gov. Accessed 20 Mar 2016.

  36. GLOBOCAN 2012 v1.1, Cancer incidence and mortality worldwide: international agency for research on cancer. http://globocan.iarc.fr. Accessed 20 Mar 2016.

  37. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst. 1994;86(21):1600–8.

    Article  CAS  PubMed  Google Scholar 

  38. Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int. 2003;91(9):789–94.

    Article  CAS  PubMed  Google Scholar 

  39. Ewing CM, Ray AM, Lange EM, Zuhlke KA, Robbins CM, Tembe WD, et al. Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med. 2012;366(2):141–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Eifler JB, Feng Z, Lin BM, Partin MT, Humphreys EB, Han M, et al. An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011. BJU Int. 2013;111(1):22–9.

    Article  PubMed  Google Scholar 

  41. Esserman LJ, Thompson Jr IM, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA. 2013;310(8):797–8.

    Article  CAS  PubMed  Google Scholar 

  42. Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C, et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014;370(10):932–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Lucca I, Klatte T, Shariat SF. Words of wisdom. Re: radical prostatectomy or watchful waiting in early prostate cancer. Eur Urol. 2014;66(2):386–7.

    Article  PubMed  Google Scholar 

  44. Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012;367(3):203–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Choo R, Klotz L, Danjoux C, Morton GC, DeBoer G, Szumacher E, et al. Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol. 2002;167(4):1664–9.

    Article  PubMed  Google Scholar 

  46. Carter HB, Kettermann A, Warlick C, Metter EJ, Landis P, Walsh PC, et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol. 2007;178(6):2359–64.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2010;28(1):126–31.

    Article  PubMed  Google Scholar 

  48. Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S, et al. Focal therapy: patients, interventions, and outcomes–a report from a consensus meeting. Eur Urol. 2015;67(4):771–7.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Shapiro RH, Johnstone PA. Risk of Gleason grade inaccuracies in prostate cancer patients eligible for active surveillance. Urology. 2012;80(3):661–6.

    Article  PubMed  Google Scholar 

  50. King CR, McNeal JE, Gill H, Presti Jr JC. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. Int J Radiat Oncol Biol Phys. 2004;59(2):386–91.

    Article  PubMed  Google Scholar 

  51. Kuru TH, Wadhwa K, Chang RT, Echeverria LM, Roethke M, Polson A, et al. Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics. BJU Int. 2013;112(5):568–77.

    Article  PubMed  Google Scholar 

  52. Barqawi AB, Rove KO, Gholizadeh S, O’Donnell CI, Koul H, Crawford ED. The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer. J Urol. 2011;186:80–5.

    Article  PubMed  Google Scholar 

  53. Bittner N, Merrick GS, Bennett A, Butler WM, Andreini HJ, Taubenslag W, et al. Diagnostic performance of initial transperineal template-guided mapping biopsy of the prostate gland. Am J Clin Oncol. 2015;38(3):300–3.

    Article  PubMed  Google Scholar 

  54. Onik G, Barzell W. Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy. Urol Oncol. 2008;26(5):506–10.

    Article  PubMed  Google Scholar 

  55. Crawford ED, Wilson SS, Torkko KC, Hirano D, Stewart JS, Brammell C, et al. Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy. BJU Int. 2005;96(7):999–1004.

    Article  PubMed  Google Scholar 

  56. Sivaraman A, Sanchez-Salas R, Barret E, Ahallal Y, Rozet F, Galiano M, et al. Transperineal template-guided mapping biopsy of the prostate. Int J Urol. 2015;22(2):146–51.

    Article  PubMed  Google Scholar 

  57. Fütterer JJ, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A, et al. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol. 2015;68(6):1045–53.

    Article  PubMed  Google Scholar 

  58. Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, et al. European society of urogenital radiology. ESUR prostate MR guidelines 2012. Eur Radiol. 2012;22(4):746–57.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, et al. PI-RADS prostate imaging – reporting and data system: 2015, Version 2. Eur Urol. 2016;69(1):16–40.

    Article  PubMed  Google Scholar 

  60. Hamoen EH, de Rooij M, Witjes JA, Barentsz JO, Rovers MM. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis. Eur Urol. 2015;67(6):1112–21.

    Article  PubMed  Google Scholar 

  61. D’Amico AV, Tempany CM, Cormack R, Hata N, Jinzaki M, Tuncali K, et al. Transperineal magnetic resonance image guided prostate biopsy. J Urol. 2000;164(2):385–7.

    Article  PubMed  Google Scholar 

  62. De Visschere PJ, Briganti A, Fütterer JJ, Ghadjar P, Isbarn H, Massard C, et al. Role of multiparametric magnetic resonance imaging in early detection of prostate cancer. Insights Imaging. 2016;7(2):205–14.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Tonttila PP, Lantto J, Pääkkö E, Piippo U, Kauppila S, Lammentausta E, et al. Prebiopsy Multiparametric magnetic resonance imaging for prostate cancer diagnosis in biopsy-naive men with suspected prostate cancer based on elevated prostate-specific antigen values: results from a randomized prospective blinded controlled trial. Eur Urol. 2016;69(3):419–25.

    Article  PubMed  Google Scholar 

  64. Quon JS, Moosavi B, Khanna M, Flood TA, Lim CS, Schieda N. False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillance. Insights Imaging. 2015;6(4):449–63.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Moore CM, Robertson NL, Arsanious N, Middleton T, Villers A, Klotz L, et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol. 2013;63(1):125–40.

    Article  PubMed  Google Scholar 

  66. Onik G, Narayan P, Vaughan D, Dineen M, Brunelle R. Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology. 2002;60(1):109–14.

    Article  PubMed  Google Scholar 

  67. Onik G, Vaughan D, Lotenfoe R, Dineen M, Brady J. The “male lumpectomy”: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol. 2008;26(5):500–5.

    Article  PubMed  Google Scholar 

  68. Bahn DK, Silverman P, Lee Sr F, Badalament R, Bahn ED, Rewcastle JC. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol. 2006;20(9):688–92.

    Article  PubMed  Google Scholar 

  69. Lambert EH, Bolte K, Masson P, Katz AE. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology. 2007;69(6):1117–20.

    Article  PubMed  Google Scholar 

  70. Ahmed HU, Freeman A, Kirkham A, Sahu M, Scott R, Allen C, et al. Focal therapy for localized prostate cancer: a phase I/II trial. J Urol. 2011;185(4):1246–54.

    Article  CAS  PubMed  Google Scholar 

  71. Ellis DS, Manny Jr TB, Rewcastle JC. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. Urology. 2007;70(6 Suppl):9–15.

    Article  PubMed  Google Scholar 

  72. de la Rosette J, Ahmed H, Barentsz J, Johansen TB, Brausi M, Emberton M, et al. Focal therapy in prostate cancer-report from a consensus panel. J Endourol. 2010;24(5):775–80.

    Article  PubMed  Google Scholar 

  73. Ward JF, Jones JS. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry. BJU Int. 2012;109(11):1648–54.

    Article  PubMed  Google Scholar 

  74. Valerio M, Emberton M, Barret E, Eberli D, Eggener SE, Ehdaie B, et al. Health technology assessment in evolution – focal therapy in localised prostate cancer. Expert Rev Anticancer Ther. 2014;14(11):1359–67.

    Article  CAS  PubMed  Google Scholar 

  75. Tempany CM, McDannold NJ, Hynynen K, Jolesz FA. Focused ultrasound surgery in oncology: overview and principles. Radiology. 2011;259(1):39–56.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Valerio M, Ahmed HU, Emberton M, Lawrentschuk N, Lazzeri M, Montironi R, et al. The role of focal therapy in the management of localised prostate cancer: a systematic review. Eur Urol. 2014;66(4):732–51.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Ahmed HU, Hindley RG, Dickinson L, Freeman A, Kirkham AP, Sahu M, et al. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol. 2012;13(6):622–32.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Azzouzi AR, Barret E, Moore CM, Villers A, Allen C, Scherz A, et al. TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer. BJU Int. 2013;112(6):766–74.

    Article  CAS  PubMed  Google Scholar 

  79. Oto A, Sethi I, Karczmar G, McNichols R, Ivancevic MK, Stadler WM, et al. MR imaging-guided focal laser ablation for prostate cancer: phase I trial. Radiology. 2013;267(3):932–40.

    Article  PubMed  Google Scholar 

  80. Li W, Fan Q, Ji Z, Qiu X, Li Z. The effects of irreversible electroporation (IRE) on nerves. PLoS One. 2011;6(4):e18831.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Valerio M, Stricker PD, Ahmed HU, Dickinson L, Ponsky L, Shnier R, et al. Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2014;17(4):343–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mastology Section, Department of Obstetrics and Gynecology, Hospital Universitario de Caracas and Centro Médico de Caracas, Caracas, Venezuela

    Isabel García-Fleury & Marco Antonio López-Tovar

  2. Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, China

    Chi-hang Yee

  3. Mastology Section, Department of Obstetrics and Gynecology, Hospital Universitario de Caracas, Centro Clínico de Maternidad Leopoldo Aguerrevere, Caracas, Venezuela

    Adriana Pesci-Feltri

  4. Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Arjun Sivaraman

  5. Department of Urology, L’Institut Mutualiste Montsouris, Paris, France

    Rafael Sanchez-Salas

Authors
  1. Isabel García-Fleury
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chi-hang Yee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marco Antonio López-Tovar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Adriana Pesci-Feltri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Arjun Sivaraman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rafael Sanchez-Salas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Isabel García-Fleury .

Editor information

Editors and Affiliations

  1. Department of Surgery, Duke Cancer Institute, Durham, North Carolina, USA

    Thomas J. Polascik

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

García-Fleury, I., Yee, Ch., López-Tovar, M.A., Pesci-Feltri, A., Sivaraman, A., Sanchez-Salas, R. (2017). Evolution in the Concept of Focal Therapy: The Story of Breast Cancer and Prostate Cancer. In: Polascik, T. (eds) Imaging and Focal Therapy of Early Prostate Cancer. Current Clinical Urology. Springer, Cham. https://doi.org/10.1007/978-3-319-49911-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-49911-6_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-49910-9

  • Online ISBN: 978-3-319-49911-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation